Skip to main content
Clinical Trials/NCT05150444
NCT05150444CompletedNot Applicable

Effects of Intradialytic Cognitive and Physical Exercise Training on Functional Status of Hemodialysis Patients: Randomized Interventional Trial

University Medical Centre Ljubljana1 site in 1 country44 target enrollmentStarted: November 2, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
44
Locations
1
Primary Endpoint
Change in Test of Attentional Performance (TAP) score

Study Overview

Brief Summary

The aim of this study is to investigate the effect of cognitive training combined with physical exercise on cognitive function, physical performance and frailty indicators in the hemodialysis population.

Detailed Description

The prevalence of cognitive impairment in hemodialysis (HD) patients is extremely high. Despite the well-documented benefits of interventions on cognitive function, there is a widespread call for effective strategies that will show the long-term consequences in patients undergoing dialysis. A randomized controlled intervention trial to examine the effects of a combined non-pharmacological intervention in the form of intradialytic physical exercise and intradialytic cognitive training on cognitive function, indicators of frailty, and physical performance measures in HD patients will be conducted. The group of patients receiving the study intervention will be compared to the control group receiving standard HD care. The duration of the intervention will be 12 weeks (3 days a week). We will use sensitive instruments (cognitive domain tests) to assess cognitive functions. The primary outcome of the study at 12 weeks will be performance on the Alertness subtest of the computerized Test of Attentional Performance. Secondary study outcomes will be: Performance in other domains of cognitive function (executive function, psychomotor speed, information processing efficiency, working memory, attention), physical fitness (10 repetition sit-to-stand test, timed up and go test, handgrip strength test, spontaneous gait speed, Stork balance test), and assessment of frailty (Edmonton Frail Scale). Study outcomes will be assessed at baseline and immediately after the 12-week intervention. This study will be among the first to test the synergistic effects of a uniquely designed physical exercise and cognitive training intervention on functional status in HD patients.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •dialysis patients on renal replacement therapy with chronic hemodialysis
  • •duration of hemodialysis treatment for at least 3 months
  • •capable of independent walking and independent feeding

Exclusion Criteria

  • •the presence of chronic malignant or infectious disease
  • •uncontrolled arterial hypertension with an average of the last five pre-dialysis blood pressure values above 180/100 mm Hg,
  • •unstable angina pectoris or Canadian Cardiovascular Society class 2-4,
  • •heart failure New York Heart Association class 3 and 4,
  • •the presence of a psychotic illness or a mental disability,
  • •a condition with an amputated limb (more than 2 fingers on the lower limb and / or more than 2 fingers on the upper limb)
  • •any other condition that causes the clinical unstability of the patient (i.e. repetitive gastrointestinal hemorrhagies, liver cirrhosis with frequent exacerbations)

Arms & Interventions

Cognitive and physical exercise training

Experimental

This group will perform combined intradialytic cognitive and physical exercise training. First, they will exercise during dialysis (3 times a week; 12 weeks) for ~30 minutes on a customized ergometer. They will start with a 3-min warm-up, then the resistance will be implied to each individual according to the rate of perceived exertion of 4th to 5th grade on a 10-grade Borg scale. After a break, they will be given tablet computers in order to play "brain games" on a CogniFit platform (~30 - 45 min).

Intervention: Cognitive and physical exercise training (Other)

Standard care

No Intervention

This group will receive standard hemodialysis care.

Outcomes

Primary Outcomes

Change in Test of Attentional Performance (TAP) score

Time Frame: baseline, after 12 weeks

The Test of Attentional Performance (TAP) is a software package that can be used primarily to examine attention functions. The rationale for the selection of the main outcome: low learning effect, most probably affected by physical exercise, attention is one of the most affected cognitive domains in dialysis patients. From the TAP test battery, subtests Alertness, Selective attention, and Divided attention will be included.

Secondary Outcomes

  • Change in hematocrit concentration(baseline, after 12 weeks)
  • Change in Symbol Digit Modalities Test (SDMT) score(baseline, after 12 weeks)
  • Change in 10 repetition sit-to-stand test time(baseline, after 12 weeks)
  • Change in Montreal Cognitive Assessment (MoCA) score(baseline, after 12 weeks)
  • Change in Trail Making Test A and B score(baseline, after 12 weeks)
  • Change in frailty score(baseline, after 12 weeks)
  • Change in Interleukin-6 concentration(baseline, after 12 weeks)
  • Change in albumin concentration(baseline, after 12 weeks)
  • Change in lean tissue index(baseline, after 12 weeks)
  • Change in spontaneous gait speed(baseline, after 12 weeks)
  • Change in Stork balance test time(baseline, after 12 weeks)
  • Change in timed-up-and go (TUG) test time(baseline, after 12 weeks)
  • Change in C-reactive protein (CRP) concentration(baseline, after 12 weeks)
  • Change in fat tissue index(baseline, after 12 weeks)
  • Change in creatinine concentration(baseline, after 12 weeks)
  • Change in sodium concentration(baseline, after 12 weeks)
  • Change in potassium concentration(baseline, after 12 weeks)
  • Change in handgrip strength (HGS) test(baseline, after 12 weeks)
  • Change in Brain-derived neurotrophic factor (BDNF) concentration(baseline, after 12 weeks)
  • Change in hemoglobin concentration(baseline, after 12 weeks)
  • Change in phosphate concentration(baseline, after 12 weeks)
  • Change in Kidney Disease Quality of Life Short Form (KDQoL-SF) score(baseline, after 12 weeks)
  • Change in urea concentration(baseline, after 12 weeks)
  • Change in mental fatigue(baseline, after 12 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Špela Bogataj

Postdoctoral Researcher

University Medical Centre Ljubljana

Study Sites (1)

Loading locations...

Similar Trials